The Dynamics of US Tularemia market growth
The US Tularemia market growth is fundamentally powered by a unique blend of public health needs and a strong biodefense agenda. While the number of naturally occurring cases of tularemia is relatively low in the United States, the market is experiencing significant growth due to the pathogen’s classification as a potential biological weapon. This has led to a consistent and substantial...
0 Commentaires 0 Parts 290 Vue 0 Aperçu